DPP-4 inhibitors repress foam cell formation by inhibiting scavenger receptors through protein kinase C pathway

Acta Diabetologica

Volumn 51, Issue 3, 2014, Pages 471-478

  Dai, Yao ^a,b   Wang, Xianwei ^b,c   Ding, Zufeng ^b   Dai, Dongsheng ^a   Mehta, Jawahar L ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^c XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

CD36; DPP 4; Foam cell formation; LOX 1; PKC

Indexed keywords

CD36 ANTIGEN; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; NVPDPP 728; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PROTEIN KINASE C; SCAVENGER RECEPTOR; SITAGLIPTIN; UNCLASSIFIED DRUG; DIPEPTIDYL PEPTIDASE IV; DPP4 PROTEIN, HUMAN; LOW DENSITY LIPOPROTEIN; PYRAZINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FOAM CELL; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL LINE; DOWN REGULATION; DRUG EFFECTS; ENZYMOLOGY; GENETICS; METABOLISM;

ATHEROSCLEROSIS; CELL LINE; DIPEPTIDYL PEPTIDASE 4; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; DOWN-REGULATION; FOAM CELLS; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; PROTEIN KINASE C; PYRAZINES; RECEPTORS, SCAVENGER; TRIAZOLES;

EID: 84905268914     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-013-0541-3     Document Type: Article

References (32)

1. Ross R, Agius L (1992) The process of atherogenesis - cellular and molecular interaction: from experimental animal models to humans. Diabetologia 35:S34-S40
2. Mehta JL (2006) Oxidized or native low-density lipoprotein cholesterol: which is more important in atherogenesis? J Am Coll Cardiol 48:980-982
3. Crucet M, Wüst SJ, Spielmann P, Lüscher TF, Wenger RH, Matter CM (2013) Hypoxia enhances lipid uptake in macrophages: role of the scavenger receptors Lox1, SRA, and CD36. Atherosclerosis 229:110-117
4. Mehta JL, Sanada N, Hu CP, Chen J, Dandapat A, Sugawara F et al (2007) Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ Res 100:1634-1642 (Pubitemid 46897266)
5. Goyal T, Mitra S, Khaidakov M, Wang X, Singla S, Ding Z et al (2012) Current concepts of the role of oxidized LDL receptors in atherosclerosis. Curr Atheroscler Rep 14:150-159
6. Mäkinen PI, Lappalainen JP, Heinonen SE, Leppänen P, Lähteenvuo MT, Aarnio JV et al (2010) Silencing of either SR-A or CD36 reduces atherosclerosis in hyperlipidaemic mice and reveals reciprocal upregulation of these receptors. Cardiovasc Res 88:530-538
7. Shiloh Y, Ziv Y (2013) The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat Rev Mol Cell Biol 14:197-210
8. Kong L, Shen X, Lin L, Leitges M, Rosario R, Zou YS et al (2013) PKCβ promotes vascular inflammation and acceleration of atherosclerosis in diabetic ApoE null mice. Arterioscler Thromb Vasc Biol 33:1779-1787
9. Ma L, Dong F, Denis M, Feng Y, Wang MD, Zha X (2011) Ht31, a protein kinase A anchoring inhibitor, induces robust cholesterol efflux and reverses macrophage foam cell formation through ATP-binding cassette transporter A1. J Biol Chem 286:3370-3378
10. Xiang J, Sun G, Mu Y, Liu H, Liu Y, Yang F et al (2011) Ritonavir stimulates foam cell formation by activating PKC. Chem Biol Interact 194:127-133
11. Namba M, Katsuno T, Kusunoki Y, Matsuo T, Miuchi M, Miyagawa J (2013) New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy. Clin Exp Nephrol 17:10-15
12. Dai Y, Dai D, Mercanti F, Ding Z, Wang X, Mehta JL (2013) Dipeptidyl peptidase-4 inhibitors in cardioprotection: a promising therapeutic approach. Acta Diabetol 50:827-835
13. Shah Z, Kampfrath T, Deiuliis JA, Zhong J, Pineda C, Ying Z et al (2011) Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis. Circulation 124:2338-2349
14. Fadini GP, Avogaro A (2011) Cardiovascular effects of DPP-4 inhibition: beyond GLP-1. Vascul Pharmacol 55:10-16
15. Matsubara J, Sugiyama S, Akiyama E, Iwashita S, Kurokawa H, Ohba K et al (2013) Dipeptidyl peptidase-4 inhibitor, sitagliptin, improves endothelial dysfunction in association with its anti-inflammatory effects in patients with coronary artery disease and uncontrolled diabetes. Circ J 77:1337-1344
16. Krijnen PA, Hahn NE, Kholová I, Baylan U, Sipkens JA, van Alphen FP et al (2012) Loss of DPP4 activity is related to a prothrombogenic status of endothelial cells: implications for the coronary microvasculature of myocardial infarction patients. Basic Res Cardiol 107:233
17. Terasaki M, Nagashima M, Watanabe T, Nohtomi K, Mori Y, Miyazaki A et al (2012) Effects of PKF275-055, a dipeptidyl peptidase-4 inhibitor, on the development of atherosclerotic lesions in apolipoprotein E-null mice. Metabolism 61:974-977
18. Terasaki M, Nagashima M, Nohtomi K, Kohashi K, Tomoyasu M, Sinmura K et al (2013) Preventive effect of dipeptidyl peptidase-4 inhibitor on atherosclerosis is mainly attributable to incretin's actions in nondiabetic and diabetic Apolipoprotein E-null mice. PLoS ONE 8:e70933
19. Park EK, Jung HS, Yang HI, Yoo MC, Kim C, Kim KS (2007) Optimized THP-1 differentiation is required for the detection of responses to weak stimuli. Inflamm Res 56:45-50 (Pubitemid 46356230)
20. Voloshyna I, Modayil S, Littlefield MJ, Belilos E, Belostocki K, Bonetti L et al (2013) Plasma from rheumatoid arthritis patients promotes pro-atherogenic cholesterol transport gene expression in THP-1 human macrophages. Exp Biol Med (Maywood) 238:1192-1197
21. Jitprasertwong P, Jaedicke KM, Nile CJ, Preshaw PM, Taylor JJ (2013) Leptin enhances the secretion of interleukin (IL)-18, but not IL-1β, from human monocytes via activation of caspase-1. Cytokine. doi:10.1016/j.cyto.2013. 10.008. [Epub ahead of print]
22. Chua S, Sheu JJ, Chen YL, Chang LT, Sun CK, Leu S et al (2013) Sitagliptin therapy enhances the number of circulating angiogenic cells and angiogenesis-evaluations in vitro and in the rat critical limb ischemia model. Cytotherapy 15:1148-1163
23. Dai Y, Mercanti F, Dai D, Wang X, Ding Z, Pothineni NV et al (2013) LOX-1, a bridge between GLP-1R and mitochondrial ROS generation in human vascular smooth muscle cells. Biochem Biophys Res Commun 437:62-66
24. Huang W, Ishii I, Zhang WY, Sonobe M, Kruth HS (2002) PMA activation of macrophages alters macrophage metabolism of aggregated LDL. J Lipid Res 43:1275-1282 (Pubitemid 34988175)
25. Dai Y, Su W, Ding Z, Wang X, Mercanti F, Chen M et al (2013) Regulation of MSR-1 and CD36 in macrophages by LOX-1 mediated through PPAR-γ. Biochem Biophys Res Commun 431:496-500
26. Liu XY, Lu Q, Ouyang XP, Tang SL, Zhao GJ, Lv YC et al (2013) Apelin-13 increases expression of ATP-binding cassette transporter A1 via activating protein kinase C α signaling in THP-1 macrophage-derived foam cells. Atherosclerosis 226: 398-407
27. Park KA, Byun HS, Won M, Yang KJ, Shin S, Piao L et al (2007) Sustained activation of protein kinase C downregulates nuclear factor-kappaB signaling by dissociation of IKK-gamma and Hsp90 complex in human colonic epithelial cells. Carcinogenesis 28:71-80 (Pubitemid 44942628)
28. Michael DR, Ashlin TG, Davies CS, Gallagher H, Stoneman TW, Buckley ML et al (2013) Differential regulation of macropinocytosis in macrophages by cytokines: implications for foam cell formation and atherosclerosis. Cytokine 64:357-361
29. Kaplan M, Aviram M, Hayek T (2012) Oxidative stress and macrophage foam cell formation during diabetes mellitus-induced atherogenesis: role of insulin therapy. Pharmacol Ther 136:175-185
30. Li D, Liu L, Chen H, Sawamura T, Ranganathan S, Mehta JL (2003) LOX-1 mediates oxidized low-density lipoprotein-induced expression of matrix metalloproteinases in human coronary artery endothelial cells. Circulation 107:612-617 (Pubitemid 36176813)
31. Lin CS, Lin FY, Ho LJ, Tsai CS, Cheng SM, Wu WL et al (2012) PKCδ signalling regulates SR-A and CD36 expression and foam cell formation. Cardiovasc Res 95:346-355
32. Antoniades C, Cunnington C, Antonopoulos A, Neville M, Margaritis M, Demosthenous M et al (2011) Induction of vascular GTP-cyclohydrolase I and endogenous tetrahydrobiopterin synthesis protect against inflammation-induced endothelial dysfunction in human atherosclerosis. Circulation 124:1860-1870